Karuna Therapeutics

About:

Karuna Therapeutics is a biopharmaceutical company that develops and delivers medicines for psychiatric and neurological conditions.

Website: https://karunatx.com

Twitter/X: KarunaPharma

Top Investors: Alexandria Venture Investments, ARCH Venture Partners, Fidelity, Wellcome Trust, Sofinnova Investments

Description:

Karuna Therapeutics is a biopharmaceutical company that develops treatments for psychiatric and neurological conditions. Karuna Therapeutics creates drugs that can significantly improve the lives of people who suffer from neurological and psychiatric illnesses, with a particular focus on schizophrenia and the behavioral symptoms of Alzheimer's disease. The company is skilled in neuroscience and has creative ideas for finding and developing new drugs. Karuna Therapeutics is advancing a pipeline of innovative drugs since its inception with the aim of significantly improving the lives of people suffering from these difficult conditions.

Total Funding Amount:

$1.6B

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)karunapharma.com

Founders:

Andrew Miller

Number of Employees:

251-500

Last Funding Date:

2023-03-21

IPO Status:

Public

© 2025 bioDAO.ai